159 related articles for article (PubMed ID: 24356466)
1. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
Li B; Zhang C; He F; Liu W; Yang Y; Liu H; Liu X; Wang J; Zhang L; Deng B; Gao F; Cui J; Liu C; Cai J
Cell Physiol Biochem; 2013; 32(6):1720-8. PubMed ID: 24356466
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
4. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.
Thotala DK; Geng L; Dickey AK; Hallahan DE; Yazlovitskaya EM
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):557-65. PubMed ID: 20117291
[TBL] [Abstract][Full Text] [Related]
5. Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763.
Brooks MM; Neelam S; Fudala R; Gryczynski I; Cammarata PR
Mol Vis; 2013; 19():1406-12. PubMed ID: 23825920
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.
Zhang H; Wang W; Fang H; Yang Y; Li X; He J; Jiang X; Wang W; Liu S; Hu J; Liu A; Dahmen U; Dirsch O
Mediators Inflamm; 2014; 2014():629507. PubMed ID: 25525303
[TBL] [Abstract][Full Text] [Related]
7. Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression.
Vines A; Cahoon S; Goldberg I; Saxena U; Pillarisetti S
J Biol Chem; 2006 Jun; 281(25):16985-16990. PubMed ID: 16601113
[TBL] [Abstract][Full Text] [Related]
8. [Role of glycogen synthase kinase 3β in maturation and function of murine myeloid dendritic cells in vitro].
Chu S; Li H; Li X; Kang X; Huang Q; Wang H; Qiu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1809-14. PubMed ID: 26714922
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.
Tan J; Geng L; Yazlovitskaya EM; Hallahan DE
Cancer Res; 2006 Feb; 66(4):2320-7. PubMed ID: 16489037
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting glycogen synthase kinase 3beta in sepsis.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
[TBL] [Abstract][Full Text] [Related]
11. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
[TBL] [Abstract][Full Text] [Related]
12. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
Chen L; Ren F; Zhang H; Wen T; Piao Z; Zhou L; Zheng S; Zhang J; Chen Y; Han Y; Duan Z; Ma Y
PLoS One; 2012; 7(9):e45202. PubMed ID: 23028846
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation.
Datusalia AK; Sharma SS
Mol Neurobiol; 2014 Oct; 50(2):390-405. PubMed ID: 24420785
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
[TBL] [Abstract][Full Text] [Related]
16. GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock.
Noh KT; Park YM; Cho SG; Choi EJ
Exp Cell Res; 2011 Jul; 317(12):1663-8. PubMed ID: 21515258
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
Ren F; Zhou L; Zhang X; Wen T; Shi H; Xie B; Li Z; Chen D; Wang Z; Duan Z
Inflammation; 2015; 38(3):1151-65. PubMed ID: 25630719
[TBL] [Abstract][Full Text] [Related]
18. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
[No Abstract] [Full Text] [Related]
19. Glycogen synthase kinase-3beta suppresses tumor necrosis factor-alpha expression in cardiomyocytes during lipopolysaccharide stimulation.
Shen E; Fan J; Peng T
J Cell Biochem; 2008 May; 104(1):329-38. PubMed ID: 18027881
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
